GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Weekly CFO Sells Highlight: CPWR, VSI, VCI, KERX, NFLX, ABC, INFA

gurujx

gurujx

1 followers
According to GuruFocus Insider Data, these are the largest CFO sells during the past week.

Compuware Corp. (CPWR): ExecVP/CFO/Treasurer Laura Lawson Fournier Sold 247,917 Shares

ExecVP/CFO/Treasurer of Compuware Corp. (CPWR) Laura Lawson Fournier sold 247,917 shares on 12/03/2010 at an average price of $11.06. Compuware Corporation provides business value through software and professional services that optimize productivity and reduce costs across the application life cycle. Compuware Corp. has a market cap of $2.5 billion; its shares were traded at around $11.41 with a P/E ratio of 24.8 and P/S ratio of 2.8. Compuware Corp. had an annual average earning growth of 9.2% over the past 10 years.

During It’s 3rd quarter, Compuware Corp. earnings per share reached 11 cents per share (GAAP) and 12 cents per share (Non-GAAP). Revenues of Covinsint- Compuware’s information ecosystem’s division- increase 22.6 percent year over year. Vantage license fees increase 9.5 percent year over year. Results for the third quarter include - Software license fees of $52.0 million compared to $53.1 million (excluding divested products) and $60.5 million (as reported) during last year’s third quarter. Maintenance and subscription fees were $117.6 million in the third quarter compared to last year’s $108.5 million (excluding divested products) and $116.6 million (as reported). Revenue from professional services in the third quarter was $60.3 million, compared to $91.5 million last year.

CPWR is in the portfolios of Dodge & Cox, Pioneer Investments, John Buckingham of Al Frank Asset Management, Inc., Richard Aster Jr of Meridian Fund, Steven Cohen of SAC Capital Advisors, Louis Moore Bacon of Moore Capital Management, LP, George Soros of Soros Fund Management LLC, Bruce Kovner of Caxton Associates.

ExecVP/CFO/Treasurer Laura Lawson Fournier sold 247,917 shares of CPWR stock on 12/03/2010 at the average price of $11.06. Executive VP,CAO Denise A Starr sold 125,000 shares of CPWR stock in December. VP, Gen. Counsel & Secretary Daniel S Jr Follis sold 15,000 shares of CPWR stock on 12/01/2010. Director William R Halling sold 10,000 shares and Senior VP, CTO Paul A Czarnik sold 40,745 shares of CPWR stock on 11/11/2010

Vitamin Shoppe Inc (VSI): CFO Michael G Archbold Sold 200,000 Shares

CFO of Vitamin Shoppe Inc (VSI) Michael G Archbold sold 200,000 shares on 12/02/2010 at an average price of $27.64. Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products. Vitamin Shoppe Inc has a market cap of $932.4 million; its shares were traded at around $33.14 with a P/E ratio of 33.1 and P/S ratio of 1.4.

Vitamin Shoppe announced its third quarter 2010 ended on September 25. Vitamin Shoppe reports that comparable store sales for the third quarter increased 7.1 percent and income from operations increased 63 percent year over year. EPS was $0.25 per share. Net sales of Vitamin Shoppe increased $19.0 million or 11.3 percent during the third quarter, to a total of $187.4 million, compared to 168.4 million during last year’s third quarter. Gross profit of the company increased 16.8 percent, or $8.8 million dollars to a total of $61.2 milllion dollars during the companies fiscal third quarter.

VSI is in the portfolios of Jim Simons of Renaissance Technologies LLC.

CEO Richard L Markee sold 75,000 shares and CFO Michael G Archbold sold 200,000 shares of VSI stock on 12/02/2010 at the average price of $27.64. 10% Owner Jeffrey Horowitz sold 358,006 shares of VSI stock on 12/07/2010 at the average price of $27.64. General Counsel James M Sander sold 10,000 shares, President and CMO Anthony N Truesdale sold 150,000 shares , VP and Chief Marketing Officer Louis Weiss sold 10,000 shares , and 10% Owner Llc Ipc/vitamin, sold 6,445,450 shares of VSI stock on 12/02/2010 at the average price of $27.64.

Valassis Communications Inc. (VCI): EVP and CFO Robert L Recchia Sold 175,000 Shares

EVP and CFO of Valassis Communications Inc. (VCI) Robert L Recchia sold 175,000 shares on 11/30/2010 at an average price of $32.65. Valassis Communications offers a wide range of marketing services to consumer packaged goods manufacturers, retailers, technology companies and other customers with operations in the United States, Europe, Mexico and Canada. Valassis Communications Inc. has a market cap of $1.67 billion; its shares were traded at around $33.64 with a P/E ratio of 17.8 and P/S ratio of 0.7.

VCI announced results for its third quarter ended September 30, 2010. Revenues for the company’s third quarter were $572.4 million, an increase of 5.2 percent compared to $544.1 million during last year’s third quarter. EPS for the quarter was $0.52, an increase of 85.7 percent compared to $0.28 during the same quarter last year. Net earnings of VCI during the third quarter were $27.0 million, an increase of 95.7 percent compared to 13.8 million for the prior year quarter.

VCI is in the portfolios of HOTCHKIS & WILEY of HOTCHKIS & WILEY Capital Management LLC, Richard Pzena of Pzena Investment Management LLC, James Barrow of Barrow, Hanley, Mewhinney & Strauss, Jeremy Grantham of GMO LLC, Steven Cohen of SAC Capital Advisors, Jim Simons of Renaissance Technologies LLC, George Soros of Soros Fund Management LLC.

President & CEO Alan F Schultz sold 135,000 shares of VCI stock on 09/20/2010 at the average price of $33.59. CEO - NCH Marketing Svcs, Inc. Brian J Husselbee sold 42,000 shares of VCI stock in July. EVP and CFO Robert L Recchia sold 28,125 shares of VCI stock on 09/20/2010 at the average price of $33.39 and 175,000 shares on 11/30/2010 at the average price of $32.65. EVP/ Sales & Marketing Richard P Herpich sold 80,000 shares of VCI stock in November through December. Director Wallace S Snyder and Director Faith Whittlesey both sold shares of VCI stock throughout November.

Keryx Biopharmaceuticals Inc. (KERX): CFO James F Oliviero Iii Sold 135,373 Shares

CFO of Keryx Biopharmaceuticals Inc. (KERX) James F Oliviero Iii sold 135,373 shares on 12/06/2010 at an average price of $5.02. Keryx Biophamaceutical, Inc. uses data discovered through the mapping of the human genome to generate drug candidates that target the regulation of protein kinases. Keryx Biopharmaceuticals Inc. has a market cap of $282.7 million; its shares were traded at around $4.62 with and P/S ratio of 11.2.

During the third quarter ended September 30, 2010, Net loss of KERX was $5.8 million or $0.10 per diluted share compared to a Net income of $0.6 million or $0.01 per diluted share during the same quarter last year. During the nine months period ended September 30, 2010, Net loss of KERX was $15 million, or $0.26 per diluted share compared to a net income of $15.1 million or $0.31 per diluted share prior year.

CEO Ron Bentsur sold 255,560 shares of KERX stock on 12/03/2010 at the average price of $5.04. CFO James F Oliviero Iii sold 147,795 shares of KERX stock throughout July, August, October and November. Director Jack Kaye sold 45,000 shares of KERX stock on 12/06/2010 at the average price of $5 and 25,000 shares of KERX stock on 09/29/2010 at the average price of $5.02.

Netflix Inc. (NFLX): CFO Barry Mccarthy Sold 100,000 Shares

CFO of Netflix Inc. (NFLX) Barry Mccarthy sold 100,000 shares on 11/30/2010 at an average price of $200.42. Netflix Inc. is the largest online movie rental subscription service in the United States providing subscribers access to a comprehensive library of more than 18,000 movie, television and other filmed entertainment titles. Netflix Inc. has a market cap of $9.84 billion; its shares were traded at around $188.23 with a P/E ratio of 71 and P/S ratio of 6. Netflix Inc. had an annual average earning growth of 106.7% over the past 5

Netflix reports its third quarter ended September 30, 2010. Netflix Inc. announced that it raised profits by 26 percent during the third quarter. Net income for the company was $38 million or 70 cents a share, which was up from the $30.1 million or 52 cents a share prior year. Also, Netflix Inc. has expanded its customer base by 52 percent from last year to 16.9 million users.

NFLX is in the portfolios of John Griffin of Blue Ridge Capital, Jim Simons of Renaissance Technologies LLC, Whitney Tilson of T2 Partners Management, LP, Kenneth Fisher of Fisher Asset Management, LLC, George Soros of Soros Fund Management LLC, Stanley Druckenmiller of Duquesne Capital Management, LLC, Louis Moore Bacon of Moore Capital Management, LP, Steven Cohen of SAC Capital Advisors, Mario Gabelli of GAMCO Investors, Jeremy Grantham of GMO LLC.

CEO Reed Hastings sold 50,000 shares of NFLX stock in September through October.CFO Barry Mccarthy sold 100,000 shares of NFLX stock on 11/30/2010 at the average price of $200.42 and 131,348 shares of NFLX stock on 11/05/2010 at the average price of $169.32.Chief Product Officer Neil D Hunt sold 4,000 shares of NFLX stock in November and 4,000 shares in December. Chief Content Officer Theodore A Sarandos sold 26,381 shares of NFLX stock on 11/08/2010 at the average price of $166.83. Marketing Officer Leslie J Kilgore and Director A George Battle sold NFLX stock.

AmerisourceBergen Corp. (ABC): Executive VP & CFO Michael D Dicandilo Sold 99,818 Shares

Executive VP & CFO of AmerisourceBergen Corp. (ABC) Michael D Dicandilo sold 99,818 shares on 12/01/2010 at an average price of $31.52. AmerisourceBergen Corporation is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Amerisourcebergen Corp. has a market cap of $8.84 billion; its shares were traded at around $31.72 with a P/E ratio of 14.5 and P/S ratio of 0.1. The dividend yield of Amerisourcebergen Corp. stocks is 1.2%. Amerisourcebergen Corp. had an annual average earning growth of 14.4% over the past 10 years. GuruFocus rated Amerisourcebergen Corp. the business predictability rank of 4.5-star.

AmerisourceBergen Corp. announced its third quarter ended June 30, 2010. EPS were $0.57 (diluted), a 36 percent increase from prior year. The company reports a revenue of $19.6 billion which was up by 6.6 percent. During the third quarter gross profit of the company was $1.8 billion, up 13 percent from prior year.

ABC is in the portfolios of David Williams of Columbia Value and Restructuring Fund, John Keeley of Keeley Fund Management, Jim Simons of Renaissance Technologies LLC, George Soros of Soros Fund Management LLC, Jeremy Grantham of GMO LLC, Bruce Kovner of Caxton Associates, Steven Cohen of SAC Capital Advisors, Mario Gabelli of GAMCO Investors.

CEO R David Yost sold 817,524 shares of ABC stock on 11/30/2010 at the average price of $30.85.Executive VP & CFO Michael D Dicandilo sold 99,818 shares of ABC stock on 12/01/2010 at the average price of $31.25.Senior Vice President John G. Chou sold 30,656 shares of ABC stock on 12/01/2010 at the average price of $31.53.Director Edward E Hagenlocker sold 19,784 shares of ABC stock on 11/19/2010 at the average price of $31.1. Director Charles H Cotros sold 19,446 shares of ABC stock on 12/06/2010 at the average price of $32.1

Informatica Corp. (INFA): CFO, EVP Finance and Administr Earl E Fry Sold 75,000 Shares

CFO, EVP Finance and Administr of Informatica Corp. (INFA) Earl E Fry sold 75,000 shares on 12/01/2010 at an average price of $42.09. Informatica Corp. is a provider of software solutions that help large companies deploy, manage, maintain and grow systems that enable more effective business decision making. Informatica Corp. has a market cap of $4.13 billion; its shares were traded at around $43.96 with a P/E ratio of 51.7 and P/S ratio of 8.2. Informatica Corp. had an annual average earning growth of 63.6% over the past 5 years.

Informatica Corp. announced its third quarter ended June 30, 2010. Total revenue’s of the company rose 31percent year over year to $161 million. Non- GAAP operating income rose by 37 percent with an operating margin of 26 percent (non-GAAP). EPS went up by $0.28 (non-GAAP).

INFA is in the portfolios of Columbia Wanger of Columbia Wanger Asset Management, Steve Mandel of Lone Pine Capital, RS Investment Management, Louis Moore Bacon of Moore Capital Management, LP, Louis Moore Bacon of Moore Capital Management, LP, Pioneer Investments, Ron Baron of Baron Funds, Jeremy Grantham of GMO LLC.

CEO, President Sohaib Abbasi sold 300,000 shares of INFA stock on 11/08/2010 at the average price of $40.98. CFO, EVP Finance and Administr Earl E Fry sold 211,965 shares of INFA stock on 08/23/2010 at the average price of $32.79 and 75,000 shares on 12/01/2010 at the average price of $42.09.Director David Pidwell sold 90,000 shares of INFA stock through November and December. Worldwide Sales Paul J Hoffman sold 32,000 shares of INFA stock on 11/17/2010 at the average price of $39.12. Ex. VP, General Manager Girish Pancha sold 100,000 shares of INFA stock on 11/09/2010 at the average price of $41.33.

For the complete list of stocks that Sold by their CFOs, go to: Insider Buys.

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 3.5/5 (10 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK